Literature DB >> 6365714

Effect of single dose of omeprazole on the gastrointestinal peptide response to food.

J M Allen, T E Adrian, J Webster, A Howe, S R Bloom.   

Abstract

The gastrointestinal peptide response to food was assessed in 6 healthy subjects following oral administration of 40 mg omeprazole. There was a small but statistically significant increase in basal plasma gastrin six hours after the dose of omeprazole, but the post-prandial plasma gastrin was not significantly increased. There was no significant effect on basal or post-prandial levels of somatostatin, insulin, pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide, pancreatic polypeptide, motilin, neurotensin, cholecystokinin, secretin, vasoactive intestinal peptide and gastrin-releasing peptide or blood glucose concentration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365714

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Effects of pirenzepine on omeprazole-induced gastrin gene expression in rat antral tissues.

Authors:  A Tari; M Hamada; T Kamiyasu; Y Fukino; M Sumii; K Sumii; G Kajiyama
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Influence of chronic omeprazole treatment on gastric endocrine function.

Authors:  H Koop; H Schwarting; A Knorr-Marin; C Willhardt; T Möser; R Arnold
Journal:  Klin Wochenschr       Date:  1987-02-16

Review 3.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 4.  Omeprazole. Overview and opinion.

Authors:  S Holt; C W Howden
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 5.  Clinical pharmacology of omeprazole.

Authors:  C W Howden
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 6.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

Review 7.  Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 8.  Omeprazole. Gastrin and gastric endocrine cell data from clinical studies.

Authors:  R G Berlin
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

9.  Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies.

Authors:  Jeong Soo Ahn; Sang Min Park; Chun Sick Eom; Sarah Kim; Seung-Kwon Myung
Journal:  Korean J Fam Med       Date:  2012-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.